This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Masahiko Koketsu: Innovator in Anti-Tumor Agents
Introduction
Masahiko Koketsu is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique compound that holds promise in cancer treatment.
Latest Patents
Koketsu holds a patent for "Uracil derivatives for use as anti-tumor agents having silicon." This patent describes an organo-silicone compound characterized by a specific formula, where various components such as X, Y, n, and R groups play crucial roles in its functionality. The compound is designed for use as an anti-tumor agent or in anti-tumor compositions, showcasing Koketsu's commitment to advancing cancer therapies. He has 1 patent to his name.
Career Highlights
Throughout his career, Masahiko Koketsu has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., a company known for its research and development in the pharmaceutical sector. His work has been instrumental in pushing the boundaries of what is possible in cancer treatment.
Collaborations
Koketsu has collaborated with esteemed colleagues such as Takahiko Mitani and Masayasu Kurono. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.
Conclusion
Masahiko Koketsu's contributions to the development of anti-tumor agents highlight his role as a key innovator in medicinal chemistry. His work continues to inspire advancements in cancer treatment and showcases the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile